Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 11 of 39

  1. velaglucerase alfa

    VPRIV Takeda

    INTRAVENOUS FDA: approved Β· EMA: approved

    A16AB10
  2. vestronidase alfa

    MEPSEVII Ultragenyx UK Limited

    EMA: approved

    A16AB18
  3. vigabatrin

    SABRIL Sanofi-aventis Healthcare Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N03AG04
  4. voclosporin

    LUVENIQ Aurinia Pharmaceuticals

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    L04AD03
  5. voriconazole

    VFEND Pfizer Australia Pty Ltd

    IV (INFUSION) FDA: approved Β· EMA: approved Β· TGA: approved

    J02AC03
  6. vosoritide

    VOXZOGO BioMarin Pharmaceutical Australia Pty Ltd

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    M05BX
  7. vutrisiran

    AMVUTTRA Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    N07XX18
  8. zanidatamab

    ZIIHERA Jazz Pharmaceuticals Ireland Limited

    EMA: approved

    L01FD07
  9. zanubrutinib

    BRUKINSA BEONE MEDICINES AUS PTY LTD

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EL03
  10. zoledronic acid

    ACLASTA Apotex Pty Ltd

    IV (INFUSION) FDA: approved Β· EMA: approved Β· TGA: approved

    M05BA08
  11. abacavir

    ZIAGEN ViiV Healthcare Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    J05AR13
  12. abaloparatide

    ELADYNOS

    SUBCUTANEOUS FDA: approved Β· EMA: approved

    H05AA04
  13. abatacept

    ORENCIA Bristol-Myers Squibb Australia Pty Ltd

    IV (INFUSION) FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L04AA24
  14. abemaciclib

    VERZENIO

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EF03
  15. abrocitinib

    CIBINQO

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    D11AH08
  16. acalabrutinib

    CALQUENCE AstraZeneca

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EL02
  17. aclidinium bromide

    BRETARIS GENUAIR

    INHALATION FDA: approved Β· EMA: approved

    R03BB
  18. adagrasib

    KRAZATI

    ORAL FDA: approved Β· EMA: approved

    L01XX77
  19. afamelanotide

    SCENESSE

    SUBCUTANEOUS FDA: approved Β· EMA: approved

    D02BB02
  20. afatinib

    GIOTRIF Boehringer Ingelheim Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L01XE13
  21. aficamten

    MYQORZO

    ORAL FDA: approved Β· EMA: approved

  22. agalsidase beta

    FABRAZYME

    INTRAVENOUS FDA: approved Β· EMA: approved

    A16AB04
  23. alemtuzumab

    LEMTRADA Sanofi-aventis Healthcare Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

    L04AA34
  24. alglucosidase alfa

    MYOZYME

    IV (INFUSION) FDA: approved Β· EMA: approved Β· PMDA: approved

    A16AB07

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.